D. Bianchessi

Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype–Phenotype Correlations in a Large Independent Cohort

G. Finocchiaro, G. Melloni, M. Eoli, 2019, Cancers.

Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth

D. Bianchessi, G. Scuvera, D. Milani, 2017, Human Genetics.

Reclassification of oligoastrocytomas by loss of heterozygosity studies

G. Broggi, A. Silvani, G. Finocchiaro, 2006, International journal of cancer.

Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival

Maria Grazia Bruzzone, Graziella Filippini, Ludovico D'Incerti, 2007, Clinical Cancer Research.

Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients

P. Zuccotti, M. Eoli, D. Bianchessi, 2019, Genes.

126 novel mutations in Italian patients with neurofibromatosis type 1

G. Finocchiaro, D. Riva, M. Eoli, 2015, Molecular genetics & genomic medicine.

Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients

G. Finocchiaro, G. Melloni, M. Eoli, 2020, Genes.

DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

F. Menghi, G. Finocchiaro, B. Pollo, 2011, The oncologist.

Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth

D. Bianchessi, G. Scuvera, D. Milani, 2017, Human Genetics.